Home | Coverage | Agents | Pulse | LogIn |
| Darwin Score | +2 |
| Ticker | CARM |
| Latest Price | 0.40 USD as of close on 03-Jul-2025 |
| 3 Month price range | 0.17 to 1.11 USD |
| Market Capitalisation | 16.84Mn USD |
| Country | United States of America |
| Region | North America |
| Economic Sector | Health Care |
| Business Sector | Pharmaceuticals, Biotechnology & Life Sciences |
| Industry | Biotechnology |
| Sub-Industry | Biotechnology |
| Description | Carisma Therapeutics, Inc., a biotechnology company, focuses on developing transformative therapies to treat liver fibrosis and cancer in the United States. Its product candidate includes CT-2401, which is in preclinical trail for the treatment of liver fibrosis. The company also develops CT-1119, a mesothelin-targeted CAR-Monocyte that is in phase I clinical trial to treat patients with advanced mesothelin-positive solid tumors, including pancreatic cancer, ovarian cancer, lung cancer, mesothelioma, and others. In addition, it develops in vivo CAR-M cell therapy to treat solid tumors, including hepatocellular carcinoma. Carisma Therapeutics, Inc. has collaboration and license agreement with ModernaTX, Inc. to address oncology gene therapies. The company was formerly known as CARMA Therapeutics Inc. and changed its name to Carisma Therapeutics, Inc. in May 2017. Carisma Therapeutics, Inc. was founded in 2016 and is headquartered in Philadelphia, Pennsylvania. See More ... |
| Company URL | https://www.carismatx.com |
| See Darwins Full Analysis for Carisma Therapeutics Inc |
Tell Me About (TMA) is Darwins structured scoring system for assets. Here are the scores from the key TMA sections for Carisma Therapeutics Inc. Further information and full detail is available when you login.
| TMA Part | Focus of Analysis | TMA Score |
|---|---|---|
| Price | Analysis of performance, trend, RSI, OBV and moving averages | -2 |
| Sentiment | News and Candle Patterns. | +1 |
| Fundamentals | Analyst Ratings, Valuation and Dividend analysis. | -3 |
| Flow | Institutional, Fund and Insider buying and selling. | 0 |
| Models | Forecast models. | +6 |
There are 1 live alerts for Carisma Therapeutics Inc. All the alerts are negative.
There are 5 peers of Carisma Therapeutics Inc.
| Asset Name | Industry Group | Perf(20d)% | Asset Score |
|---|---|---|---|
| Klotho Neurosciences Inc (KLTO) | Biotechnology | +529.8 | +28 |
| Ligand Pharmaceuticals Inc (LGND) | Biotechnology | +10.4 | +18 |
| Protagonist Therapeutics Inc (PTGX) | Biotechnology | -0.9 | +24 |
| Vericel Corp (VCEL) | Biotechnology | -3.3 | +3 |
| Xencor Inc (XNCR) | Biotechnology | -7.5 | -28 |
To see complete information on Carisma Therapeutics Inc or any other assets please login.
If you do not already have an account you can register for a free trial of our service. This will let you explore all the analytical information we have on price, fundamantals, flow, sentiments & models for all the stocks under coverage. You will then be able to compare asset scores and perform a wide range of multi asset analysis such as Market Cycles and Relative Scores.
Follow Us | |
©2025 Darwin Knows - All Rights Reserved | |